EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of an Affibody-based Molecular Probe and 18 F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT

Xiaoyi Guo iD, Nina Zhou iD, Jiayue Liu iD, Jin Ding iD, Teli Liu iD, Guohong Song iD, Hua Zhu, Zhi Yang iD

Radiology · 01.06.2024 · 311 (3)

DOI: 10.1148/radiol.232209 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Radiology, erschienen am 01.06.2024. Verfasst von Xiaoyi Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Breast Neoplasms, Positron Emission Tomography Computed Tomography, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In participants with human epidermal growth factor receptor 2–positive breast cancer, the affibody-based tracer Al 18 F-NOTA-HER2-BCH enabled detection of more primary lesions and lymph node, bone, and liver metastases than fluorine 18 fluorodeoxyglucose on PET/CT images.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Breast NeoplasmsPositron Emission Tomography Computed TomographyErb-b2 Receptor Tyrosine KinasesRadiopharmaceuticalsHumansFemaleMiddle AgedProspective StudiesAgedAdultRecombinant Fusion Proteins

Substanzen

Fluorodeoxyglucose F18Erb-b2 Receptor Tyrosine KinasesRadiopharmaceuticalsRecombinant Fusion ProteinsERBB2 protein, human

Autor:innen und Institutionen

  • From the Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), D…

ORCID-Profile: Xiaoyi Guo, Nina Zhou, Jiayue Liu, Jin Ding, Teli Liu, Guohong Song, Zhi Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Guo, X., Zhou, N., Liu, J., Ding, J., Liu, T., Song, G., Zhu, H., & Yang, Z. (2024). Comparison of an Affibody-based Molecular Probe and 18 F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT. Radiology, 311(3). https://doi.org/10.1148/radiol.232209

Vancouver

Guo X, Zhou N, Liu J, Ding J, Liu T, Song G, et al. Comparison of an Affibody-based Molecular Probe and 18 F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT. Radiology. 2024;311(3). doi:10.1148/radiol.232209

BibTeX
@article{Guo2024,
  author = {Guo, Xiaoyi and Zhou, Nina and Liu, Jiayue and Ding, Jin and Liu, Teli and Song, Guohong and Zhu, Hua and Yang, Zhi},
  title = {Comparison of an Affibody-based Molecular Probe and 18 F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT},
  journal = {Radiology},
  year = {2024},
  volume = {311},
  number = {3},
  doi = {10.1148/radiol.232209}
}
Kostenlos starten →